#818 on the rich list of 14,644 insiders
James N. Wilson
Director at Corcept Therapeutics. Based in Redwood City, California.
$226M
in disclosed stock, −$9.8M (−4.15%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 818th of 14,644
- Companies held
- 1
- Largest holding
- CORT, 100.0% of total
- Latest SEC filing
- Nov 13, 2026
What the $226M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Corcept Therapeutics CORT Common Stock | Indirectly (see filing footnote) | 1,134,532 | $64.98 | $73.7M | 32.6% | Form 4, Feb 24, 2026 |
| Corcept Therapeutics CORT Common Stock | James N. Wilson and Pamela D. Wilson Trust | 1,104,543 | $64.98 | $71.8M | 31.7% | Form 4, May 27, 2026 |
| Corcept Therapeutics CORT Common Stock | James N. Wilson and Pamela D. Wilson Trust | 1,044,543 | $64.98 | $67.9M | 30.0% | Form 4, Nov 13, 2026 |
| Corcept Therapeutics CORT Common Stock | Pamela D. Wilson 2025 Grantor Retained Annuity Trust | 200,000 | $64.98 | $13.0M | 5.7% | Form 4, Nov 13, 2026 |
Share counts are the amounts James N. Wilson reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | Sold | CORT | 2,191 | $71.80 | $157K | View |
| Nov 13, 2026 | Sold | CORT | 7,221 | $72.87 | $526K | View |
| Nov 13, 2026 | Sold | CORT | 563 | $73.42 | $41K | View |
| Nov 13, 2026 | Sold | CORT | 25 | $74.28 | $2K | View |
| Oct 15, 2026 | Sold | CORT | 6,654 | $114.48 | $762K | View |
| Oct 15, 2026 | Sold | CORT | 3,046 | $115.39 | $351K | View |
| Oct 15, 2026 | Sold | CORT | 300 | $116.30 | $35K | View |
| Sep 15, 2026 | Sold | CORT | 2,800 | $111.70 | $313K | View |
| Sep 15, 2026 | Sold | CORT | 400 | $110.84 | $44K | View |
| Sep 15, 2026 | Sold | CORT | 6,800 | $110.27 | $750K | View |
| Aug 14, 2026 | Sold | CORT | 3,053 | $110.49 | $337K | View |
| Aug 14, 2026 | Sold | CORT | 2,279 | $112.64 | $257K | View |
| Aug 14, 2026 | Sold | CORT | 4,668 | $111.44 | $520K | View |
| Jul 15, 2026 | Sold | CORT | 1,079 | $86.78 | $94K | View |
| Jul 15, 2026 | Sold | CORT | 3,969 | $87.74 | $348K | View |
| Jul 15, 2026 | Sold | CORT | 1,978 | $89.49 | $177K | View |
| Jul 15, 2026 | Sold | CORT | 2,974 | $88.81 | $264K | View |
| Jun 16, 2026 | Sold | CORT | 4,177 | $82.69 | $345K | View |
| Jun 16, 2026 | Sold | CORT | 5,823 | $83.57 | $487K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 815 | Seifi Ghasemi Chairman, Pres. and CEO, Air Products and Chemicals. Allentown, PA | $229M |
| 816 | Wai Kwong Poon Chief Executive Officer, BUUU Group | $228M |
| 817 | Yael Aflalo Director, Reformation. Vernon, CA | $227M |
| 818 | James N. Wilson Director, Corcept Therapeutics. Redwood City, CA | $226M |
| 819 | Kenneth L. Cornick Director, Clear Secure | $226M |
| 820 | Hung, David PRESIDENT AND CEO, Nuvation Bio. Wayne, PA | $226M |
| 821 | Oguzhan Atay Chairman and CEO, BillionToOne. Menlo Park, CA | $225M |
Other Corcept Therapeutics insiders
All CORT insiders- Joseph K. Belanoff$368MChief Executive Officer. #580 overall
- David L Mahoney$154MDirector. #1077 overall
- G. Leonard Baker Jr.$146MDirector. #1126 overall
- Hazel Hunt$16.6MChief Scientific Officer. #5953 overall
- Gary Charles Robb$4.8MChief Business Officer. #14604 overall
Questions
How much stock does James N. Wilson own?
James N. Wilson holds $226,365,498 in listed stock based on SEC filings and current prices, mostly Corcept Therapeutics (CORT). That ranks 818th on the Stock Rich List.
Is this James N. Wilson's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did James N. Wilson last buy or sell stock?
The most recent open-market trade on file is a sale of 2,191 CORT shares on Nov 13, 2026 at $71.80.